Susan G. Kreissman

Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma

Alice L. Yu, Andrew L. Gilman, M. Fevzi Özkaynak et al. · New England Journal of Medicine · 2010 · 1.8K citations · Full text

Medicine, Immunology, Oncology +14

Selumetinib in paediatric patients with BRAF-aberrant or neurofibromatosis type 1-associated recurrent, refractory, or progressive low-grade glioma: a multicentre, phase 2 trial

Jason Fangusaro, Arzu Onar‐Thomas, Tina Young Poussaint et al. · The Lancet Oncology · 2019 · 502 citations · Full text

Medicine, Oncology, Pediatrics +16

A randomized comparison between rasburicase and allopurinol in children with lymphoma or leukemia at high risk for tumor lysis

Stanton Goldman, John S. Holcenberg, Jerry Z. Finklestein et al. · Blood · 2001 · 476 citations · Full text

Medicine, Pediatrics, Pharmacology +13

Effect of Tandem Autologous Stem Cell Transplant vs Single Transplant on Event-Free Survival in Patients With High-Risk Neuroblastoma

Julie R. Park, Susan G. Kreissman, Wendy B. London et al. · JAMA · 2019 · 357 citations · Full text

Medicine, Immunology, Oncology +14

Purged versus non-purged peripheral blood stem-cell transplantation for high-risk neuroblastoma (COG A3973): a randomised phase 3 trial

Susan G. Kreissman, Robert C. Seeger, Katherine K. Matthay et al. · The Lancet Oncology · 2013 · 309 citations · Full text

Medicine, Hematology, Oncology +10